Private Market View

Chuchuang Biotechnology

Changsha, China · Founded 2020 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include Hunan Lushan Technology Investment.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 1 names
  • ·Watchlist + deal alerts for Chuchuang Biotechnology
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Chuchuang Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Chuchuang Biotechnology

Manufacturerr of medical devices, food safety testing products, and smart diagnostic equipment catering to healthcare providers, food safety regulators, and related industries seeking reliable diagnostic and testing tools. The company uses intelligent systems, electronic instrumentation, and quantum information technology, along with the development of Internet of Things (IoT) technologies, and provides comprehensive solutions for medical diagnostics and food safety testing, enabling them to improve diagnostic accuracy, ensure food safety, and enhance operational efficiency through advanced biotechnology applications.

Sector
Healthcare
HQ
Changsha, China
Founded
2020
Ownership
Privately Held (backing)
PA Mark — not yet priced

Chuchuang Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Chuchuang Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Chuchuang Biotechnology in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.